Global Migraine Drugs Market ,2016–2024
The increasing awareness regarding a migraine and various options available for its treatment are the major factors boosting the growth of the global migraine drugs market
The increasing awareness regarding a migraine and various options available for its treatment are the major factors boosting the growth of the global migraine drugs market
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Published By: Zion <strong>Market</strong> Research<br />
<strong>Migraine</strong> <strong>Drugs</strong> <strong>Market</strong>: <strong>Global</strong> Industry Analysis, Size, Share, Growth,<br />
Trends, and Forecasts <strong>2016–2024</strong><br />
Contact Us:<br />
4283, Express Lane, Suite 634-143,<br />
Sarasota, Florida 34249, United States<br />
Tel: +1-386-310-3803 GMT<br />
Tel: +49-322 210 92714<br />
USA/Canada Toll Free No.1-855-465-4651<br />
sales@zionmarketresearch.com
<strong>Migraine</strong> <strong>Drugs</strong> <strong>Market</strong><br />
<strong>Global</strong> <strong>Migraine</strong> <strong>Drugs</strong> <strong>Market</strong>: Overview<br />
About 12–14% of people around the world suffer from a <strong>Migraine</strong>; it is a type of a headache.<br />
According to regional and international rules, migraine is classified by the nature of the<br />
attack and its frequency into a chronic migraine and episodic migraine. Prophylactic and<br />
abortive are 2 treatments available for the relief of this headache type. Prophylactic<br />
treatment is offered to patients suffering from a chronic migraine in order to avoid migraine<br />
attacks utilizing medications like topiramate, botulinum toxin, and others. Abortive treatment<br />
is offered to terminate severe migraine attack and includes medication like ergot alkaloids,<br />
triptans, and others.<br />
Request Free Sample Report @ https://www.zionmarketresearch.com/sample/migrainedrugs-market<br />
<strong>Global</strong> <strong>Migraine</strong> <strong>Drugs</strong> <strong>Market</strong>: Growth Factors<br />
The increasing awareness regarding a migraine and various options available for its<br />
treatment are the major factors boosting the growth of the global migraine drugs market. A<br />
number of organizations including the American Headache and <strong>Migraine</strong> Association are<br />
taking efforts to spread awareness about a migraine and hence coming up with programs<br />
and providing support to patients so as to spread awareness regarding the disease and
<strong>Migraine</strong> <strong>Drugs</strong> <strong>Market</strong><br />
further disorders related to a headache. Due to the increasing number of migraine<br />
incidences and rising number of unmet needs in the global migraine drugs market, a<br />
number of companies are planning to invest in the migraine drugs R&D. This, in turn, is<br />
anticipated to propel the global migraine drugs market growth in the near future.<br />
<strong>Global</strong> <strong>Migraine</strong> <strong>Drugs</strong> <strong>Market</strong>: Segmentation<br />
The global migraine drugs market is segmented on the basis of treatment type, route of<br />
administration, and distribution channel. On the basis of treatment type, the global migraine<br />
drugs market is segmented as prophylactic and abortive. The prophylactic treatment<br />
segment is further sub-segmented as topiramate, botulinum toxin, and others. The abortive<br />
treatment segment is further sub-segmented as ergot alkaloids, triptans, and others. On the<br />
basis of route of administration, the global market is classified as injectable, oral, and<br />
others. The others segment is further sub-segmented as transdermal patches and nasal<br />
sprays. On the basis of distribution channel, the global migraine drugs market is diversified<br />
as hospital pharmacies, retail pharmacies, and others.<br />
Request Report TOC (Table of Contents) @<br />
https://www.zionmarketresearch.com/toc/migraine-drugs-market<br />
<strong>Global</strong> <strong>Migraine</strong> <strong>Drugs</strong> <strong>Market</strong>: Regional Analysis<br />
Asia Pacific is anticipated to dominate the global migraine drugs market and is further<br />
expected to continue this trend in the near future. This high growth is mainly owing to the
<strong>Migraine</strong> <strong>Drugs</strong> <strong>Market</strong><br />
increasing number of people having from a migraine and rising public awareness of the<br />
disease in this region. In addition, China and India are the major developing countries<br />
contributing to the global migraine drugs market growth in the Asia Pacific region; this is<br />
mainly due to the high occurrence of a migraine in these countries. Rising focus on niche<br />
products and their launches along with high penetration of novel drug manufacturers will<br />
further have a positive impact on the growth of the global migraine drugs market in the near<br />
future.<br />
Browse detail report @ https://www.zionmarketresearch.com/report/migraine-drugsmarket<br />
<strong>Global</strong> <strong>Migraine</strong> <strong>Drugs</strong> <strong>Market</strong>: Competitive Players<br />
Some of the major players in the global migraine drugs market include Endo, Allergan,<br />
Impax Laboratories, Glaxo Smith Kline, Astellas, Amgen, Bayer, AstraZeneca, Dr. Reddy's<br />
Laboratories, Zogenix, CoLucid, Eli Lilly, Eisai, IntelGenx, Ethypharm, and Klara. Other key<br />
players dominating the global market are Johnson & Johnson, Luitpold Pharmaceuticals,<br />
Kowa Pharmaceuticals America, Merck, Meda, Pfizer, OptiNose, Raptor, Pozen, SUDA,<br />
Redhill, TG Therapeutics, Teva, Winston Pharmaceuticals, and Valeant.<br />
For Media Inquiry contact our sales Team @ sales@zionmarketresearch.com
<strong>Migraine</strong> <strong>Drugs</strong> <strong>Market</strong><br />
Zion <strong>Market</strong> Research<br />
Address: 4283, Express Lane, Suite 634-143, Sarasota, Florida 34249, United States<br />
Tel: +1-386-310-3803 GMT<br />
+49-322 210 92714 Tel: +1-855-465-4651 (US/CAN TOLL FREE)<br />
Email: sales@zionmarketresearch.comWeb:www.zionmarketresearch.com
Change language